XNAS: GALT
Galectin Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (G...
Read More
2.43
0.21
(9.46%)
402.5K
XNAS Volume
XNAS 09 Apr, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Galectin Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..